A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease
Public ClinicalTrials.gov record NCT03922711. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Three-Arm, Parallel-Group Study to Assess the Efficacy and Safety of Two Doses of Pridopidine Versus Placebo for the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease (gLIDe)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, randomized, three-arm, parallel-group, double-blind, placebo-controlled, study to evaluate the efficacy, safety and pharmacokinetics (PK) of pridopidine vs. placebo for the treatment of Levodopa Induced Dyskinesia (LID) in patients with Parkinson Disease.
Study identification
- NCT ID
- NCT03922711
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 23 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 22, 2019 (Actual)
- Primary completion
- Jul 22, 2020 (Actual)
- Completion
- Jul 22, 2020 (Actual)
- Last update posted
- Jul 1, 2022
2019 – 2020
United States locations
- U.S. sites
- 33
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Prilenia Investigational Site (Site 117) | Birmingham | Alabama | 35233 | — |
| Prilenia Investigational Site (Site 144) | Phoenix | Arizona | 85004 | — |
| Prilenia Investigational Site (Site 111) | Phoenix | Arizona | 85013 | — |
| Prilenia Investigational Site (Site 115) | Scottsdale | Arizona | 85259 | — |
| Prilenia Investigational Site (Site 106) | Fountain Valley | California | 92708 | — |
| Prilenia Investigational Site (Site 109) | Irvine | California | 92697 | — |
| Prilenia Investigational Site (Site 105) | Pasadena | California | 91105 | — |
| Prilenia Investigational Site (Stie 142) | Torrance | California | 90502 | — |
| Prilenia Investigational Site (Site 136) | Aurora | Colorado | 80045 | — |
| Prilenia Investigational Site (Site 135) | Englewood | Colorado | 80113 | — |
| Prilenia Investigational Site (Site 118) | Boca Raton | Florida | 33431 | — |
| Prilenia Investigational Site (Site 131) | Maitland | Florida | 32751 | — |
| Prilenia Investigational Site (Site 122) | Sunrise | Florida | 33351 | — |
| Prilenia Investigational Site (Site 116) | Tampa | Florida | 33612 | — |
| Prilenia Investigational Site (Site 138) | Atlanta | Georgia | 30329 | — |
| Prilenia Investigational Site (Stie 123) | Augusta | Georgia | 30912 | — |
| Prilenia Investigational Site (Site 107) | Iowa City | Iowa | 52242 | — |
| Prilenia Investigational Site (Site 102) | Kansas City | Kansas | 66160 | — |
| Prilenia Investigational Site (Site 126) | Omaha | Nebraska | 68198 | — |
| Prilenia Investigational Site (Site 141) | New Brunswick | New Jersey | 08901 | — |
| Prilenia Investigational Site (Site 128) | Amherst | New York | 14226 | — |
| Prilenia Investigational Site (Site 147) | New York | New York | 10029 | — |
| Prilenia Investigational Site (Site 101) | Raleigh | North Carolina | 27607 | — |
| Prilenia Investigational Site (Site 127) | Raleigh | North Carolina | 27612 | — |
| Prilenia Investigational Site (Site 149) | Dayton | Ohio | 45459 | — |
| Prilenia Investigational Site (Site 139) | Tulsa | Oklahoma | 74136 | — |
| Prilenia Investigational Site (Site 114) | Philadelphia | Pennsylvania | 19107 | — |
| Prilenia Investigational Site (Site 146) | Willow Grove | Pennsylvania | 19090 | — |
| Prilenia Investigational Site (Site 119) | Providence | Rhode Island | 02903 | — |
| Prilenia Investigational Site (Site 120) | Houston | Texas | 77030 | — |
| Prilenia Investigational Site (Site 121) | Houston | Texas | 77030 | — |
| Prilenia Investigational Site (Site 129) | San Antonio | Texas | 78230 | — |
| Prilenia Investigational Site (Site 103) | Kirkland | Washington | 98034 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03922711, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2022 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03922711 live on ClinicalTrials.gov.